Jennifer Lalama

FDA investigator

Appears on 31 documents from 2015 to 2026, mostly at sites in Florida. Most often cites production record review (21 CFR 211.192).

31
Documents on file
4.7
Observations per 483
2015
First seen
2026
Most recent

What they cite most

From 144 observations

Activity by year

2015: 1, 2016: 5, 2017: 6, 2018: 2, 2019: 3, 2021: 3, 2022: 6, 2023: 1, 2024: 1, 2025: 1, 2026: 2

Where

Florida 25 · South Carolina 2 · Spain 2 · Mississippi 1 · Puerto Rico 1

Is Jennifer Lalama coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

31 documents, newest first
FirmOpen
483 Charles River Laboratories, Inc. DBAMar 27, 2026 · Charleston, South Carolina
483 Charles River Laboratories, Inc.Mar 27, 2026 · Charleston, South Carolina
483 SKNVMar 6, 2025 · Pompano Beach, Florida
483 Dextrum Laboratories IncAug 29, 2024 · Miami, Florida
483 Rovi Pharma Industrial Services S.A.Sep 22, 2023 · San Sebastian De Los Reyes, Spain
483 RAPHA Health Network International, IncDec 16, 2022 · Doral, Florida
483 Chemco CorporationOct 31, 2022 · Hialeah, Florida

About this profile

What does Jennifer Lalama inspect?

Jennifer Lalama appears on 31 documents on file covering 27 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.165 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jennifer Lalama is dated Mar 27, 2026.